PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21.


Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
17 10 2019
Historique:
received: 16 05 2019
accepted: 13 09 2019
pubmed: 20 9 2019
medline: 21 10 2020
entrez: 20 9 2019
Statut: epublish

Résumé

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by pathologic T cell-B cell interactions and autoantibody production. Defining the T cell populations that drive B cell responses in SLE may enable design of therapies that specifically target pathologic cell subsets. Here, we evaluated the phenotypes of CD4+ T cells in the circulation of 52 SLE patients drawn from multiple cohorts and identified a highly expanded PD-1hiCXCR5-CD4+ T cell population. Cytometric, transcriptomic, and functional assays demonstrated that PD-1hiCXCR5-CD4+ T cells from SLE patients are T peripheral helper (Tph) cells, a CXCR5- T cell population that stimulates B cell responses via IL-21. The frequency of Tph cells, but not T follicular helper (Tfh) cells, correlated with both clinical disease activity and the frequency of CD11c+ B cells in SLE patients. PD-1hiCD4+ T cells were found within lupus nephritis kidneys and correlated with B cell numbers in the kidney. Both IL-21 neutralization and CRISPR-mediated deletion of MAF abrogated the ability of Tph cells to induce memory B cell differentiation into plasmablasts in vitro. These findings identify Tph cells as a highly expanded T cell population in SLE and suggest a key role for Tph cells in stimulating pathologic B cell responses.

Identifiants

pubmed: 31536480
pii: 130062
doi: 10.1172/jci.insight.130062
pmc: PMC6824311
doi:
pii:

Substances chimiques

CD11c Antigen 0
CXCR5 protein, human 0
Interleukins 0
MAF protein, human 0
PDCD1 protein, human 0
Programmed Cell Death 1 Receptor 0
Proto-Oncogene Proteins c-maf 0
Receptors, CXCR5 0
interleukin-21 MKM3CA6LT1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAMS NIH HHS
ID : K08 AR072791
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067679
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR065538
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30 AR070253
Pays : United States

Références

Diabetologia. 2019 Sep;62(9):1681-1688
pubmed: 31270583
J Immunol. 2016 Aug 15;197(4):1023-8
pubmed: 27430719
Nature. 2019 Jul;571(7763):122-126
pubmed: 31189952
J Exp Med. 2010 Feb 15;207(2):365-78
pubmed: 20142430
Nat Immunol. 2019 Jul;20(7):928-942
pubmed: 31061532
Arthritis Rheumatol. 2015 Oct;67(10):2723-31
pubmed: 26097207
Proc Natl Acad Sci U S A. 2011 May 10;108(19):7932-7
pubmed: 21518858
Sci Transl Med. 2014 Apr 2;6(230):230ra46
pubmed: 24695686
Science. 2009 Aug 21;325(5943):1001-5
pubmed: 19628815
Arthritis Rheum. 2011 Jan;63(1):63-72
pubmed: 20882667
Nat Immunol. 2015 Jul;16(7):755-65
pubmed: 26006014
J Immunol. 2017 Apr 1;198(7):2578-2588
pubmed: 28219887
Lupus. 2015 Aug;24(9):909-17
pubmed: 25654980
Annu Rev Immunol. 2011;29:621-63
pubmed: 21314428
J Immunol. 2012 Apr 15;188(8):3734-44
pubmed: 22427637
Nature. 2017 Feb 1;542(7639):110-114
pubmed: 28150777
Front Immunol. 2018 Mar 05;9:427
pubmed: 29556239
J Clin Invest. 2019 Jul 2;129(8):3185-3200
pubmed: 31264971
Immunity. 2013 Oct 17;39(4):770-81
pubmed: 24138884
Nat Med. 2019 Jan;25(1):75-81
pubmed: 30478422
Nat Commun. 2016 Feb 26;7:10875
pubmed: 26915335
Immunol Rev. 2016 Jan;269(1):118-29
pubmed: 26683149
J Immunol. 2009 Feb 1;182(3):1421-8
pubmed: 19155489
Nat Protoc. 2015 Feb;10(2):316-33
pubmed: 25612231
Nat Immunol. 2019 Jul;20(7):915-927
pubmed: 31110316
Nature. 2005 May 26;435(7041):452-8
pubmed: 15917799
Arthritis Rheumatol. 2015 Apr;67(4):988-99
pubmed: 25581113
Arthritis Rheum. 2002 Oct 15;47(5):546-55
pubmed: 12382306
Nat Commun. 2018 May 1;9(1):1758
pubmed: 29717110
J Immunol. 2011 Feb 1;186(3):1849-60
pubmed: 21187439
Cytometry A. 2013 May;83(5):483-94
pubmed: 23512433
Arthritis Rheum. 2010 Jan;62(1):234-44
pubmed: 20039395
J Exp Med. 2008 Nov 24;205(12):2873-86
pubmed: 18981236
Cytometry A. 2015 Jul;87(7):636-45
pubmed: 25573116
Immunity. 2018 Oct 16;49(4):725-739.e6
pubmed: 30314758
Arthritis Rheumatol. 2014 Jun;66(6):1583-95
pubmed: 24644022
Front Immunol. 2018 Aug 23;9:1924
pubmed: 30190721
J Clin Invest. 2015 Jan;125(1):292-303
pubmed: 25485678
J Immunol. 2001 Aug 15;167(4):2361-9
pubmed: 11490026
Nat Immunol. 2018 Apr;19(4):407-419
pubmed: 29483597
Nat Immunol. 2019 Jul;20(7):902-914
pubmed: 31209404
Cell. 2016 Apr 21;165(3):551-65
pubmed: 27040498
Arthritis Rheum. 2003 May;48(5):1332-42
pubmed: 12746906
Eur J Immunol. 2016 Feb;46(2):281-90
pubmed: 26614103
Nat Commun. 2017 Aug 15;8(1):254
pubmed: 28811467
Immunity. 2018 Dec 18;49(6):1034-1048.e8
pubmed: 30566881
Nat Med. 2019 May;25(5):734-737
pubmed: 30911136
Cell Syst. 2018 May 23;6(5):612-620.e5
pubmed: 29605184

Auteurs

Alexandra V Bocharnikov (AV)

Division of Rheumatology, Immunology, and Allergy.

Joshua Keegan (J)

Department of Surgery.

Vanessa S Wacleche (VS)

Division of Rheumatology, Immunology, and Allergy.

Ye Cao (Y)

Division of Rheumatology, Immunology, and Allergy.

Chamith Y Fonseka (CY)

Center for Data Sciences, and.
Division of Rheumatology and Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.
Broad Institute of Massachusetts Institute and Technology and Harvard University, Cambridge, Massachusetts, USA.

Guoxing Wang (G)

Oncology & Immunology Discovery, and.

Eric S Muise (ES)

Oncology & Immunology Discovery, and.
Genetics and Pharmacogenomics, Merck & Co. Inc., Boston, Massachusetts, USA.

Kelvin X Zhang (KX)

Oncology & Immunology Discovery, and.
Genetics and Pharmacogenomics, Merck & Co. Inc., Boston, Massachusetts, USA.

Arnon Arazi (A)

Broad Institute of Massachusetts Institute and Technology and Harvard University, Cambridge, Massachusetts, USA.

Gregory Keras (G)

Division of Rheumatology, Immunology, and Allergy.

Zhihan J Li (ZJ)

Division of Rheumatology, Immunology, and Allergy.

Yujie Qu (Y)

Oncology & Immunology Discovery, and.

Michael F Gurish (MF)

Division of Rheumatology, Immunology, and Allergy.

Michelle Petri (M)

Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA.

Jill P Buyon (JP)

Division of Rheumatology, New York University School of Medicine, New York, New York, USA.

Chaim Putterman (C)

Department of Microbiology & Immunology and Division of Rheumatology, Albert Einstein College of Medicine, Bronx, New York, USA.

David Wofsy (D)

Rheumatology Division and Russell/Engleman Research Center, UCSF, San Francisco, California, USA.

Judith A James (JA)

Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.

Joel M Guthridge (JM)

Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.

Betty Diamond (B)

Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases, The Feinstein Institute for Medical Research, Northwell Health, Manhasset, New York, USA.

Jennifer H Anolik (JH)

Department of Medicine, Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA.

Matthew F Mackey (MF)

Oncology & Immunology Discovery, and.

Stephen E Alves (SE)

Oncology & Immunology Discovery, and.

Peter A Nigrovic (PA)

Division of Rheumatology, Immunology, and Allergy.
Division of Immunology, Boston Children's Hospital, Boston, Massachusetts, USA.

Karen H Costenbader (KH)

Division of Rheumatology, Immunology, and Allergy.

Michael B Brenner (MB)

Division of Rheumatology, Immunology, and Allergy.

James A Lederer (JA)

Department of Surgery.

Deepak A Rao (DA)

Division of Rheumatology, Immunology, and Allergy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH